Acute rejection and cytomegalovirus infection: correlation with cardiac allograft vasculopathy
Mangiavacchi, M.; Frigerio, M.; Gronda, E.; Danzi, G.B.; Bonacina, E.; Masciocco, G.; Olivia, F.; De Vita, C.; Pellegrini, A.
Transplantation Proceedings 27(3): 1960-1962
1995
ISSN/ISBN: 0041-1345 PMID: 7792851 Document Number: 444893
Document emailed within 1 workday
Related Documents
Shao, Y.L.; Shelby, J.; Hisatake, G.; Kern, E.R.; Nelson, E.W.; Gay, W.A. 1991: Accelerated cardiac allograft rejection in murine cytomegalovirus-infected C3H recipients Transplantation Proceedings 23(1 Part 1): 129-130Barker, A.K.; McDaniel, D.Olga.; Zhou, X.; He, Z.; Aru, G.; Thomas, T.; Moore, C.K. 2010: Combined analysis of allograft inflammatory factor-1, interleukin-18, and Toll-like receptor expression and association with allograft rejection and coronary vasculopathy American Surgeon 76(8): 872-878
Nickel, P.; Lacha, J.; Ode-Hakim, S.; Sawitzki, B.; Babel, N.; Frei, U.; Volk, H.D.; Reinke, P. 2001: Cytotoxic effector molecule gene expression in acute renal allograft rejection: correlation with clinical outcome; histopathology and function of the allograft Transplantation 72(6): 1158-1160
Zhang, Q-Wei.; Tomita, Y.; Matsuzaki, G.; Shimizu, I.; Iwai, T.; Okano, S.; Minagawa, R.; Nakashima, Y.; Sueishi, K.; Nomoto, K.; Yasui, H. 2002: Heart allograft tolerance without development of posttransplant cardiac allograft vasculopathy in chimerism-based, drug-induced tolerance Transplantation 73(4): 652-656
Sakurai, M.; Fukuyama, N.; Iguchi, A.; Akimoto, H.; Ohmi, M.; Yokoyama, H.; Nakazawa, H.; Tabayashi, K. 1999: Quantitative analysis of cardiac 3-L-nitrotyrosine during acute allograft rejection in an experimental heart transplantation Transplantation 68(11): 1818-1822
Dumont, L.; Stanley, P.; Chartrand, C. 1985: Hemodynamic effects of hypertonic sodium bicarbonate in canine cardiac allograft recipients during acute rejection Transplantation Proceedings 17(4): 1966-1972
Miller, L.W. 1995: Role of intracoronary ultrasound for the diagnosis of cardiac allograft vasculopathy Transplantation Proceedings 27(3): 1989-1992
Szeto, W.Y.; Krasinskas, A.M.; Kreisel, D.; Krupnick, A.S.; Popma, S.H.; Rosengard, B.R. 2002: Depletion of recipient CD4+ but not CD8+ T lymphocytes prevents the development of cardiac allograft vasculopathy Transplantation 73(7): 1116-1122
Klauss, V.; Rieber, J.; Uberfuhr, P.; Theisen, K.; Mudra, H. 1995: Qualitative and quantitative assessment of cardiac allograft vasculopathy by intravascular ultrasound Transplantation Proceedings 27(3): 1975-1976
Savolainen, H.; Frösen, J.; Petrov, L.; Häyry, P. 2001: Expression of the vasculoprotective estrogen receptor subtype beta in rat and human cardiac allograft vasculopathy Transplantation Proceedings 33(1-2): 1605
Aziz, T.; Hasleton, P.; Hann, A.W.; Yonan, N.; Deiraniya, A.; Hutchinson, I.V. 2000: Transforming growth factor beta in relation to cardiac allograft vasculopathy after heart transplantation Journal of Thoracic and Cardiovascular Surgery 119(4 Pt 1): 700-708
Eggensperger, D.; O'Dowd, G.; Schweitzer, S.; Light, J. 1987: The clinical efficacy of cytodiagnostic urinalysis in the diagnosis of acute renal allograft rejection: a clinical-pathologic correlation of 122 urine specimens Transplantation Proceedings 19(1 Pt 2): 1787-1788
Jordan, S.C.; Quartel, A.W.; Czer, L.S.; Admon, D.; Chen, G.; Fishbein, M.C.; Schwieger, J.; Steiner, R.W.; Davis, C.; Tyan, D.B. 1998: Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action Transplantation 66(6): 800-805
Hengster, P.; Pescovitz, M.D.; Hyatt, D.; Margreiter, R. 1999: Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection. Roche Study Group Transplantation 68(2): 310-313
Chartrand, C.; Stanley, P. 1979: Delayed rejection of cardiac allograft following coronary washout Transplantation Proceedings 11(1): 594-598
Pirenne, J.; Médot, M.; Battafarano, R.; Benedetti, E.; Kim, S.; Dunn, D.L. 1996: Does endotoxin accelerate rejection in a cardiac allograft model? Transplantation Proceedings 28(5): 2463-2464
Miller, L.W. 1990: Treatment of cardiac allograft rejection with intravenous corticosteroids Journal of Heart Transplantation 9(3 Pt 2): 283-287
DiStefano, R.; Kupiec-Weglinski, J.W.; Uhteg, L.C.; Puskas, J.; Araneda, D.; Diamantstein, T.; Tilney, N.L. 1988: Modulation of accelerated rat cardiac allograft rejection by cyclosporine and ART-18 Transplantation Proceedings 20(2 Suppl 2: 217-222
Carrier, M.; Russell, D.H.; Davis, T.P.; Emery, R.W.; Copeland, J.G. 1988: Urinary polyamines as markers of cardiac allograft rejection. a clinical evaluation Journal of Thoracic and Cardiovascular Surgery 96(5): 806-810
Kurtz, J.B.; Thompson, J.F.; Ting, A.; Pinto, A.; Morris, P.J. 1984: The problem of cytomegalovirus infection in renal allograft recipients Quarterly Journal of Medicine 53(211): 341-349